94824 ⎘
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups - ; Five-membered rings; Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings 1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
HETEROCYCLIC COMPOUNDS AND USES THEREOF
#2COMPOUND, ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME, AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME
#3INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
#4HETEROCYCLIC COMPOUNDS AND USES THEREOF
#5PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF
#6PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF
#7PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF
#8PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF
#9COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#10SMALL-MOLECULE COMPOUND HAVING NAPHTHALENETHIOL ETHER STRUCTURE, AND USE THEREOF
#11CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS
#12COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES
#13BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#14NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#15COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF
#16Compositions and methods for the treatment of cancer
#17CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
#18Protein tyrosine phosphatase inhibitors and methods of use thereof
#19Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination
#20Protein tyrosine phosphatase inhibitors and methods of use thereof
#21Viral replication inhibitors
#22Thionyl tetrafluoride modified compounds and uses
#23ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#24Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#25Compounds as indoleamine 2,3-dioxygenase inhibitors
#26Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#27Conjugated polymers
#28Prostamides for the treatment of glaucoma and related diseases
#29ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#30Anti-enterovirus 71 thiadiazolidine derivative
#31Viral replication inhibitors
#32Inhibition of WNT, TGF beta and Hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders
#33ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#34CYCLIC AMIDE DERIVATIVE
#35Arginine methyltransferase inhibitors and uses thereof
#36CETP INHIBITORS
#37Selective androgen receptor modulators
#38Prostamides for the treatment of glaucoma and related diseases
#39Cyclic amide derivative
#40Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt
#41Cyclic amide derivative
#42Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#43LIGHT EMITTING TETRAPHENYLENE DERIVATIVES, ITS METHOD FOR PREPARATION AND LIGHT EMITTING DEVICE USING THE SAME DERIVATIVES
#44Fluorinated monomers, oligomers and polymers for use in organic electronic devices
#45Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer
#46Novel Compounds
#47Compounds as antagonists or inverse agonists at opioid receptors
#481,3,4-TRISUBSTITUTED BENZENES
#491-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
#50PROCESS OF PREPARING A RADIOACTIVE COMPOUND CONTAINING A FLUORINE-18 ISOTOPE
#51N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof
#52Method for preparing doped organic semiconductor materials and formulation utilized therein
#53Organic Compounds
#54Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#55Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#56CETP inhibitors
#57Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#58Insecticidal compounds
#591-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as PTP-as inhibitors
#60aSMase inhibitors
#61Substituted hydroxyethylamine aspartyl protease inhibitors
#62Organic compounds
#63Heteroarylcarbamoylbenzene derivatives
#64Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
#651,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
#66Method of detection, separation and identification for expressed trace protein/peptide
#67Organic compounds
#685-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives
#69Anti-inflammatory medicaments
#70Cetp Inhibitors
#71Cyclic ureas used as inhibitors of metalloproteases
#72Thiadiazoles as CXC- and CC- chemokine receptor ligands
#73Anti-inflammatory medicaments
#74Prostamides for the treatment of glaucoma and related diseases
#75Benzo[1,2,5]thiadiazole compounds
#76Therapeutic guanidines
#77Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
#78Process for preparing nitrooxy esters, nitrooxy thioesters nitrooxy carbonates and nitrooxy thiocarbinates, intermediates useful in said process and preparation thereof
#79N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#80Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#81Nitrooxyderivatives of antihypertensive drugs
#82Anti-inflammatory medicaments
#83SOLVENT CONTAINING 1,2,5-THIADIAZOLE COMPOUND, AND METHOD FOR EXTRACTING AN ORGANIC COMPOUND USING THE SOLVENT
#84Compounds
#85Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#86Thiadiazoles AS CXC- and CC- chemokine receptor ligands
#87Heteroarylcarbamoylbenzene derivative
#88Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#891,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety
#90CETP inhibitors
#91Anti-inflammatory medicaments
#92Compounds which inhibit leukocyte adhesion mediated by VLA-4
#93Substituted hydroxyethylamine aspartyl protease inhibitors
#94Bisarylsulfonamide compounds and their use in cancer therapy
#95Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#96Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
#97Supported group 8-10 transition metal olefin polymerization catalysts
#985-substituted 1,1-dioxo-1,2,5,-thiadiazolidin-3-one derivatives